<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">469060069</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323132854.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170328e19920901xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF01041363</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF01041363</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Szejtli</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">CYCLOLAB, Cyclodextrin Research and Development Laboratory, Budapest, Hungary</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="4">
   <subfield code="a">The properties and potential uses of cyclodextrin derivatives</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[J. Szejtli]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The hydroxyl groups can be selectively substituted to control the solubility and the complex forming selectivity of the modified cyclodextrins (CDs). Among the methylated CDs only two well-defined compounds can be taken into consideration: dimethyl- and dimethyl-βCD (DIMEB and TRIMEB). In an aqueous solution of DIMEB the solubility of rather insoluble compounds and drugs like steroids, vitamin D3, lidocaine and hydrocortisone increases. In some cases their stability and bioavailability are also improved. On the other hand, the hydrolysis rate of carmofur, coumarins etc. is retarded by the methylated cyclodextrins with blocked hydroxyl groups. The drug solubilizing capacity of hydroxypropyl-βCD (HPBCD) is in most cases lower than that of DIMEB. The degree of substitution (DS) shows no remarkable effect on the solubilizing properties of HPBCD in the case of indomethacin, Dipiridamole etc., but in the case of Tolnaftate the solubility was enhanced by increasing the DS, other examples are shown.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Kluwer Academic Publishers, 1992</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">cyclodextrin derivatives</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">solubility</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">drug carrier characteristics</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">complex formation</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Journal of inclusion phenomena and molecular recognition in chemistry</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">14/1(1992-09-01), 25-36</subfield>
   <subfield code="x">0923-0750</subfield>
   <subfield code="q">14:1&lt;25</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">14</subfield>
   <subfield code="o">10847</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF01041363</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">review-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF01041363</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">100</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Szejtli</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">CYCLOLAB, Cyclodextrin Research and Development Laboratory, Budapest, Hungary</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Journal of inclusion phenomena and molecular recognition in chemistry</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">14/1(1992-09-01), 25-36</subfield>
   <subfield code="x">0923-0750</subfield>
   <subfield code="q">14:1&lt;25</subfield>
   <subfield code="1">1992</subfield>
   <subfield code="2">14</subfield>
   <subfield code="o">10847</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
